Future prospective clinical studies are warranted to confirm the prognostic importance of MLH1 V384D, as well as to define appropriate combinations of anti-cancer therapeutics in treating tumors with concomitant existence of EGFR L858R and MLH1 V384D alleles. Here, MLH1 is linked to cancer.